A dearly beloved wife, mum and granny is among those remembered in this week's funeral notices. Pamela Kathleen (Pam) Finnemore passed away peacefully at her home with her family around her on June 25 ...

Every notice published to our newspaper and news site also appears on funeral-notices.co.uk - the UK’s number one site for death notices and memoriams. Every notice remains online forever providing ...

Experts at the Royal Devon and the University of Exeter are using genetics and other testing to identify individuals at high risk of developing type 1 diabetes, with the hope that more people could be ...

Prince William and Kate Middleton are making a noticeable change in how they balance their royal duties with their personal lives.

Devon County Show is proud to announce that it will host the Devon Cattle Breeders Society’s National Show in 2026. The National Show—traditionally held at venues across the country and most recently ...

Emergency services have confirmed that someone is in hospital after an off-road crash on the M5 Motorway today (Friday, July 11).

Emergency services have confirmed that someone is in hospital after an off-road crash on the M5 Motorway today (Friday, July 11).

Stock photo: Devon Air Ambulance. A motorcyclist has been airlifted to hospital with serious injuries after a crash near Honiton, sparking an appeal for witnesses. The emergency services were called ...

Redmayne Bentley, one of the UK’s longest-established independent investment management, stockbroking and financial planning firms, celebrated its 150th anniversary with a midsummer celebration at the ...

Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes.

Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: “Excitingly, teplizumab is the first drug with the potential to delay type 1 ...

Dr Nick Thomas, the diabetes consultant treating Ms Robinson at the Royal Devon and Exeter Hospital (RD&E), said Teplizumab was the first therapy "which actually targets the underlying problem".